Operating Lease, Right-of-Use Asset of AVANOS MEDICAL, INC. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AVANOS MEDICAL, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • AVANOS MEDICAL, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $27,600,000, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AVANOS MEDICAL, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $27,600,000 -$6,500,000 -19% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $29,900,000 +$3,400,000 +13% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $31,100,000 +$1,700,000 +5.8% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $32,100,000 +$7,900,000 +33% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $34,100,000 +$7,300,000 +27% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $26,500,000 -$600,000 -2.2% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $29,400,000 +$300,000 +1% 30 Jun 2024 10-Q 31 Jul 2024 2024 Q2
Q1 2024 $24,200,000 -$4,100,000 -14% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $26,800,000 -$700,000 -2.5% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $27,100,000 -$5,400,000 -17% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $29,100,000 -$4,800,000 -14% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $28,300,000 -$7,800,000 -22% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $27,500,000 -$11,100,000 -29% 31 Dec 2022 10-K 21 Feb 2024 2023 FY
Q3 2022 $32,500,000 -$8,900,000 -21% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $33,900,000 -$9,000,000 -21% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $36,100,000 -$9,000,000 -20% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $38,600,000 -$9,700,000 -20% 31 Dec 2021 10-K 21 Feb 2023 2022 FY
Q3 2021 $41,400,000 -$15,100,000 -27% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $42,900,000 -$17,100,000 -28% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $45,100,000 -$14,800,000 -25% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $48,300,000 -$15,700,000 -25% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $56,500,000 -$7,500,000 -12% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $60,000,000 -$7,200,000 -11% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $59,900,000 +$5,000,000 +9.1% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $64,000,000 31 Dec 2019 10-K 19 Feb 2021 2020 FY
Q3 2019 $64,000,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $67,200,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $54,900,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.